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Bioethicists in the United States have long debated whether our health care system---in which the majority of Americans receive care via employment‐based insurance[^1^](#hast1126-bib-0001){ref-type="ref"} and under which for‐profit health providers are a major force---is politically or ethically appropriate. Covid‐19 has revealed a further flaw in this system.

There are two main barriers to pandemic treatment in the United States. The first is that, as Covid‐19 has shown, a large number of people will reliably lose access to employment‐based health care when a health crisis harms the economy. At least 17 million Americans have lost their jobs due to the effects of the pandemic, and many of these people have therefore lost access to their employer‐sponsored health insurance. Simultaneously, a large portion of the population has been sickened by Covid‐19 itself.

This phenomenon is not primarily due to management of the crisis caused by the pandemic. Prior to Covid‐19, the Federal Emergency Management Agency predicted this outcome of any pandemic,[^2^](#hast1126-bib-0002){ref-type="ref"} and the United States has not been alone during Covid‐19 in experiencing a surge in unemployment.[^3^](#hast1126-bib-0003){ref-type="ref"} The phenomenon is also not a result of individual bad luck. It is a result of how the health care system is organized.

The second barrier is competition between health care providers, which threatens the provision of appropriate medical care in an unexpected large‐scale health event. Because for‐profit health care providers are competing for clients, they are incentivized to compete with one another for medical supplies when those supplies are scarce, and that competition will disrupt any fair distribution of supplies.

This worst‐case outcome seems to have come to pass in the wake of Covid‐19. Before tests were generally available, boutique health care providers offered wealthy clients and celebrities near‐unlimited access to coronavirus tests.[^4^](#hast1126-bib-0004){ref-type="ref"} This was not intentionally harmful behavior through these practices; it was a rational effort on the part of the providers to serve their clients.

The existing regulation of competition between health care providers is not enough to prevent this problem, and devising regulations that could succeed would be difficult. A system in which health care providers are incentivized to compete is one in which providers, in order to protect their own patients, will (rationally) seek to get around regulations that mandate how to distribute health care supplies. In the case of Covid‐19, regulations have not successfully prevented widely disparate provision of medical supplies like N‐95s masks and ventilators.

The impetus to compete for medical supplies also subjects health care providers to the power of other actors. President Trump has been accused of using the distribution of limited personal protective equipment to gain influence over individual states.[^5^](#hast1126-bib-0005){ref-type="ref"} True or not, this accusation highlights a serious possibility. If health care providers have an incentive to compete for medical supplies, in a crisis, these providers are at risk of having bad actors use this competition to unduly influence them.

The U.S. health care system therefore systematically breaks down along three different lines when faced with a pandemic---and will do so in future public health crises if nothing changes. There are two possible ways to fix this: enacting stringent regulation to prevent these outcomes or rejecting the system\'s basic structure. To prevent these breakdowns, regulations would have to be made much stronger and further reaching. I do not know what regulations would succeed, or if such regulation is possible. Restructuring the American health care system would be difficult, but the path forward is much clearer. A restructuring would have to involve a rejection of employment‐based health insurance and of competition between health care providers. If we want the people in the United States to receive appropriate, equitable treatment in the next pandemic, we must take up one of these two tasks.
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